These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10908504)

  • 1. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Deane KH
    Cochrane Database Syst Rev; 2000; 2001(3):CD001517. PubMed ID: 10908504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Deane KH
    Cochrane Database Syst Rev; 2001; (1):CD001517. PubMed ID: 11279719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropinirole for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Deane KH
    Cochrane Database Syst Rev; 2000; (3):CD001516. PubMed ID: 10908503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Deane KH
    Cochrane Database Syst Rev; 2001; (1):CD001516. PubMed ID: 11279718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Deane KD
    Cochrane Database Syst Rev; 2001; 2001(1):CD001519. PubMed ID: 11279721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke C E; Speller J M; Clarke J A
    Cochrane Database Syst Rev; 2000; 2000(3):CD002259. PubMed ID: 10908539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
    Deane KH; Spieker S; Clarke CE
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004553. PubMed ID: 15495118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cabergoline for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Deane KH
    Cochrane Database Syst Rev; 2001; 2001(1):CD001518. PubMed ID: 11279720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
    Clarke C E; Speller J M
    Cochrane Database Syst Rev; 2000; (2):CD000236. PubMed ID: 10796705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramipexole for levodopa-induced complications in Parkinson's disease.
    Clarke C E; Speller J M; Clarke J A
    Cochrane Database Syst Rev; 2000; 2000(3):CD002261. PubMed ID: 10908540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Speller JM
    Cochrane Database Syst Rev; 2000; 1999(2):CD001514. PubMed ID: 10796800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials.
    Kulisevsky J; Pagonabarraga J
    Drug Saf; 2010 Feb; 33(2):147-61. PubMed ID: 20082541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pergolide for levodopa-induced complications in Parkinson's disease.
    Clarke C E; Speller J M
    Cochrane Database Syst Rev; 2000; (2):CD000235. PubMed ID: 10796704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C; van Hilten JJ
    Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH; Ha JH; Cho IS; Lee MC
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.
    Deane KH; Spieker S; Clarke CE
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004554. PubMed ID: 15495119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
    Stowe R; Ives N; Clarke CE; Deane K; ; Wheatley K; Gray R; Handley K; Furmston A
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007166. PubMed ID: 20614454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
    Brunt ER; Brooks DJ; Korczyn AD; Montastruc JL; Stocchi F;
    J Neural Transm (Vienna); 2002 Apr; 109(4):489-502. PubMed ID: 11956968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisuride for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Speller JM
    Cochrane Database Syst Rev; 2000; 1999(2):CD001515. PubMed ID: 10796801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine versus levodopa in early Parkinson's disease.
    van Hilten JJ; Ramaker CC; Stowe R; Ives NJ
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD002258. PubMed ID: 17943771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.